The Journal of Prevention of Alzheimer's Disease
Publisher: Elsevier · ISSN 2274-5807 · 44 articles
- Editorial Board
- Content
- Opportunities to treat specific populations with repurposed drugs
- What's good for the heart is good for the brain? Evidence from a rural cohort on the longitudinal relationship between atherosclerotic cardiovascular disease risk and cognitive decline
- From advice to agency: making brain health actionable and equitable for middle-aged adults with mild neurocognitive disorder
- Frailty in the anti-amyloid era: an opportunity to individualize care
- Risk of Dementia after initiation of GLP-1 RA versus long-acting insulin in patients with type 2 Diabetes mellitus
- Increasing cardiovascular disease risk predicts faster cognitive decline: A Bayesian analysis of a cohort of adults in rural West Texas
- Brain health strategies in middle-aged individuals with mild neurocognitive disorder: a scoping review
- Integrating frailty into decision-making for disease-modifying therapies in Alzheimer’s disease: a proposed expert-opinion based approach
- Comprehensive social determinants of health and brain health in midlife
- The missing improvers: Tau pathology, neuroplasticity, and the case for tau-informed patient selection before amyloid immunotherapy
- Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181
- Relative importance of blood-based biomarkers for Alzheimer’s disease-specific neurodegeneration and cognitive decline
- Beyond MRI associations: refining clinical interpretation in anti-amyloid therapy
- Psychological adversities and epigenetic ageing in midlife and older age: A systematic review and meta-analysis
- Timing of cognitive decline onset and life-course trajectories A pooled longitudinal analysis of 14,389 adults across three cohorts
- Cost-effectiveness of the special care unit for persons with dementia
- Quantifying generalization error in machine learning prediction of cognitive decline
- Choroid plexus volume in pathology-confirmed Alzheimer's disease
- Predictive value of the Alzheimer polygenic risk score on cognitive decline in patients with mild cognitive impairment and Alzheimer's disease dementia
- Prevalence of dementia and BPSD in community-dwelling older adults with advanced care needs: a nationwide survey in Taiwan
- National Prevalence and Care Needs of Dementia in Adults Aged >=55 Years: Findings from the China Mental Health Survey
- From regulatory approval to clinical practice: real-world eligibility for anti-amyloid monoclonal antibodies in an Italian dementia-care network
- Oxidation over omega-3: Reinterpreting the paradoxical link between fish oil supplements and accelerated cognitive decline
- Do methodological limitations and confounding factors explain the apparent acceleration of cognitive decline in older adults taking omega-3 fatty acid supplements?
- Response to two letters on omega-3 supplementation and cognitive decline
- Advancing the Alzheimer’s disease research and care pipeline with agentic artificial intelligence: Opportunities, challenges, and priorities from the international clinical trials on Alzheimer’s disease (CTAD) task force
- Prevalence, risk factors, and racial disparities in probable and possible dementia: the national health and aging trends study
- Characterization of a metabolomics signature of the brain-health-promoting MIND diet in older persons